SWOG clinical trial number
SWOG-8790 (INT-0083) (GOG-133)
A Randomized Trial of Adjuvant Intraperitoneal Recombinant Interferon Alpha-2 in Stage III Ovarian Carcinoma in Patients Who Have No Evidence of Disease After Surgery and Chemotherapy
Closed
Phase
Accrual
53%
Published
Abbreviated Title
Adjuvant Interferon in Stage 3 Ovarian Cancer
Activated
03/01/1988
Closed
06/15/1999
Research committees
Gynecologic Cancer
Treatment
Interferon alpha 2a
Publication Information Expand/Collapse
2006
Randomized trial of adjuvant intraperitoneal alpha-interferon in Stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: An intergroup study